bexarotene capsules — Medica
cutaneous T-cell lymphoma
Initial criteria
- Patient has cutaneous manifestations/lesions
- Medication is prescribed by or in consultation with an oncologist or a dermatologist
Approval duration
1 year
cutaneous T-cell lymphoma
1 year